OBJECTIVE: To describe obstacles in the implementation of a controlled treatment trial of adolescent anorexia nervosa (AN). METHOD: The original aim was to enter 240 participants with AN to one of four cells: Behavioral family therapy (BFT) plus fluoxetine; BFT plus placebo; systems family therapy (SFT) plus fluoxetine; SFT plus placebo. RESULTS: Recruitment was delayed pending a satisfactory resolution concerning participant safety. After 6 months of recruitment it became clear that the medication was associated with poor recruitment leading to a study redesign resulting in a comparison of two types of family therapy with a projected sample size of 160. One site was unable to recruit and was replaced. DISCUSSION: Problems with the delineation of safety procedures, recruitment, re-design of the study, and replacement of a site, were the main elements resulting in a 1-year delay. Suggestions are made for overcoming such problems in future AN trials.
RCT Entities:
OBJECTIVE: To describe obstacles in the implementation of a controlled treatment trial of adolescent anorexia nervosa (AN). METHOD: The original aim was to enter 240 participants with AN to one of four cells: Behavioral family therapy (BFT) plus fluoxetine; BFT plus placebo; systems family therapy (SFT) plus fluoxetine; SFT plus placebo. RESULTS: Recruitment was delayed pending a satisfactory resolution concerning participant safety. After 6 months of recruitment it became clear that the medication was associated with poor recruitment leading to a study redesign resulting in a comparison of two types of family therapy with a projected sample size of 160. One site was unable to recruit and was replaced. DISCUSSION: Problems with the delineation of safety procedures, recruitment, re-design of the study, and replacement of a site, were the main elements resulting in a 1-year delay. Suggestions are made for overcoming such problems in future AN trials.
Authors: A L Robin; P T Siegel; A W Moye; M Gilroy; A B Dennis; A Sikand Journal: J Am Acad Child Adolesc Psychiatry Date: 1999-12 Impact factor: 8.829
Authors: Neville H Golden; Debra K Katzman; Richard E Kreipe; Sarah L Stevens; Susan M Sawyer; Jane Rees; Dasha Nicholls; Ellen S Rome Journal: J Adolesc Health Date: 2003-12 Impact factor: 5.012
Authors: Christina A Roberto; Joanna Steinglass; Laurel E S Mayer; Evelyn Attia; B Timothy Walsh Journal: Int J Eat Disord Date: 2008-09 Impact factor: 4.861
Authors: James Lock; Daniel Le Grange; W Stewart Agras; Kathleen Kara Fitzpatrick; Booil Jo; Erin Accurso; Sarah Forsberg; Kristen Anderson; Kate Arnow; Maya Stainer Journal: Behav Res Ther Date: 2015-08-01
Authors: Eileen Fairbanks; Shivani Shah; Mary H Wilde; Margaret V McDonald; Judith Brasch; James M McMahon Journal: Appl Nurs Res Date: 2014-04-18 Impact factor: 2.257
Authors: W Stewart Agras; James Lock; Harry Brandt; Susan W Bryson; Elizabeth Dodge; Katherine A Halmi; Booil Jo; Craig Johnson; Walter Kaye; Denise Wilfley; Blake Woodside Journal: JAMA Psychiatry Date: 2014-11 Impact factor: 21.596
Authors: Sarah Forsberg; Kathleen Kara Fitzpatrick; Alison Darcy; Vandana Aspen; Erin C Accurso; Susan W Bryson; Stewart Agras; Katherine D Arnow; Daniel Le Grange; James Lock Journal: Int J Eat Disord Date: 2014-08-20 Impact factor: 4.861
Authors: Guido K W Frank; Megan E Shott; Jennifer O Hagman; Marissa A Schiel; Marisa C DeGuzman; Brogan Rossi Journal: Int J Eat Disord Date: 2017-03-23 Impact factor: 4.861
Authors: Joanna E Steinglass; Anne Marie Albano; H Blair Simpson; Yuanjia Wang; Jingjing Zou; Evelyn Attia; B Timothy Walsh Journal: Int J Eat Disord Date: 2013-11-08 Impact factor: 4.861